Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy.
Watanabe T, Kaji R, Oka N, Bara W, Kimura J. Watanabe T, et al. Among authors: bara w. J Neurol Sci. 1994 Apr;122(2):140-3. doi: 10.1016/0022-510x(94)90290-9. J Neurol Sci. 1994. PMID: 8021696
[Anti-ganglioside antibodies and motor neuropathy in relation to nerve conduction block].
Kaji R, Nishio T, Bara W, Mesaki T, Matsui H, Akiguchi I, Kimura J. Kaji R, et al. Among authors: bara w. No To Shinkei. 1992 Aug;44(8):691-8. No To Shinkei. 1992. PMID: 1419346 Review. Japanese. No abstract available.
SEPSIS project: a protocol for studying biomarkers of neonatal sepsis and immune responses of infants in a malaria-endemic region.
Fievet N, Ezinmegnon S, Agbota G, Sossou D, Ladekpo R, Gbedande K, Briand V, Cottrell G, Vachot L, Yugueros Marcos J, Pachot A, Textoris J, Blein S, Lausten-Thomsen U, Massougbodji A, Bagnan L, Tchiakpe N, d'Almeida M, Alao J, Dossou-Dagba I, Tissieres P; SEPSIS study group collaborators; SEPSIS study group. Fievet N, et al. BMJ Open. 2020 Jul 23;10(7):e036905. doi: 10.1136/bmjopen-2020-036905. BMJ Open. 2020. PMID: 32709653 Free PMC article.
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
Di Tanna GL, Khaki AR, Theron G, McCarthy K, Cox H, Mupfumi L, Trajman A, Zijenah LS, Mason P, Bandason T, Durovni B, Bara W, Hoelscher M, Clowes P, Mangu C, Chanda D, Pym A, Mwaba P, Cobelens F, Nicol MP, Dheda K, Churchyard G, Fielding K, Metcalfe JZ. Di Tanna GL, et al. Among authors: bara w. Lancet Glob Health. 2019 Feb;7(2):e191-e199. doi: 10.1016/S2214-109X(18)30458-3. Lancet Glob Health. 2019. PMID: 30683238 Free PMC article.
Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial.
Calligaro GL, Zijenah LS, Peter JG, Theron G, Buser V, McNerney R, Bara W, Bandason T, Govender U, Tomasicchio M, Smith L, Mayosi BM, Dheda K. Calligaro GL, et al. Among authors: bara w. Lancet Infect Dis. 2017 Apr;17(4):441-450. doi: 10.1016/S1473-3099(16)30384-X. Epub 2017 Jan 5. Lancet Infect Dis. 2017. PMID: 28063795 Clinical Trial.
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mason P, Hopewell PC. Metcalfe JZ, et al. Among authors: bara w. Int J Tuberc Lung Dis. 2016 Jul;20(7):882-9. doi: 10.5588/ijtld.15.0696. Int J Tuberc Lung Dis. 2016. PMID: 27287639 Free PMC article.
Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients.
Metcalfe JZ, Makumbirofa S, Makamure B, Mutetwa R, Peñaloza RA, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P. Metcalfe JZ, et al. Among authors: bara w. Eur Respir J. 2015 May;45(5):1504-6. doi: 10.1183/09031936.00214114. Epub 2015 Mar 18. Eur Respir J. 2015. PMID: 25792637 Free PMC article. No abstract available.
Drug-resistant tuberculosis in high-risk groups, Zimbabwe.
Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P. Metcalfe JZ, et al. Among authors: bara w. Emerg Infect Dis. 2014 Jan;20(1):135-7. doi: 10.3201/eid2001.130732. Emerg Infect Dis. 2014. PMID: 24377879 Free PMC article.
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, Dowdy D, Pym A, Mwaba P, Mason P, Peter J, Dheda K; TB-NEAT team. Theron G, et al. Among authors: bara w. Lancet. 2014 Feb 1;383(9915):424-35. doi: 10.1016/S0140-6736(13)62073-5. Epub 2013 Oct 28. Lancet. 2014. PMID: 24176144 Clinical Trial.
Feedback